Ward M M
Veterans Affairs/Robert Wood Johnson Clinical Scholars Program, Palo Alto Veterans Affairs Medical Center, CA 94304.
J Rheumatol. 1994 Jan;21(1):17-27.
To determine the relative accuracy and sensitivity to change of 14 measures commonly used to assess arthritis activity in patients with rheumatoid arthritis (RA).
Twenty-four patients with RA were prospectively examined every 2 weeks for up to 60 weeks. At each examination, arthritis activity was assessed using 5 physician determined measures (global assessment, swollen joint count, weighted swollen joint count, tender count, weighted tender joint count), 3 patient determined measures (global assessment, pain score, duration of morning stiffness), 3 functional measures (Health Assessment Questionnaire Disability Index, grip strength, 50' walk time), and 3 laboratory measures [Westergren erythrocyte sedimentation rate (ESR), hemoglobin, platelet count]. Accuracy was determined by the degree to which changes in each measure over time were related to changes in other measures (i.e., correlational validity). Sensitivity to change was measured using standardized response means.
Over the course of the study, each patient had at least 6 measures change more than 50% from their baseline values. The most highly intercorrelated measures were the physician global assessment (range of partial correlations r = 0.4-0.7), patient global assessment and pain scores (r = 0.2-0.7), the Disability Index (r = 0.3-0.7), and ESR (r = 0.2-0.4). Physician and patient global assessments, pain scores, and the Disability Index were more sensitive to change than other measures, while laboratory measures were generally less sensitive to change.
Based on the relative accuracy and sensitivity to change of these 14 clinical measures, the physician global assessment, a functional status questionnaire, and the patient global assessment or pain score should be the principal measures used to assess arthritis activity in patients with RA. Recognizing its limitations, the ESR could be included if a laboratory measure is needed.
确定常用于评估类风湿性关节炎(RA)患者关节炎活动度的14项指标的相对准确性及对变化的敏感性。
对24例RA患者进行前瞻性研究,每2周检查一次,共持续60周。每次检查时,使用5项由医生确定的指标(整体评估、肿胀关节计数、加权肿胀关节计数、压痛计数、加权压痛关节计数)、3项由患者确定的指标(整体评估、疼痛评分、晨僵持续时间)、3项功能指标(健康评估问卷残疾指数、握力、50英尺步行时间)以及3项实验室指标[魏氏血沉率(ESR)、血红蛋白、血小板计数]来评估关节炎活动度。准确性通过各指标随时间的变化与其他指标变化的相关程度来确定(即相关效度)。使用标准化反应均值来衡量对变化的敏感性。
在研究过程中,每位患者至少有6项指标相对于基线值变化超过50%。相关性最高的指标是医生整体评估(偏相关系数r范围为0.4 - 0.7)、患者整体评估和疼痛评分(r = 0.2 - 0.7)、残疾指数(r = 0.3 - 0.7)以及ESR(r = 0.2 - 0.4)。医生和患者的整体评估、疼痛评分以及残疾指数对变化比其他指标更敏感,而实验室指标通常对变化较不敏感。
基于这14项临床指标的相对准确性及对变化的敏感性,医生整体评估、一项功能状态问卷以及患者整体评估或疼痛评分应作为评估RA患者关节炎活动度的主要指标。认识到其局限性,如果需要一项实验室指标,ESR可以纳入。